Clinical Trial Update: Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1

View source ↗

Summary

A recruiting clinical trial is evaluating an AI algorithm based on melanoma peri-scar dermatoheliosis as a predictive factor for response to anti-PD-1 therapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 inhibitor (anti-PD-1) (PD-1 inhibitor)

Snippet

Sponsor: Nantes University Hospital | Conditions: Metastatic Melanoma | Status: RECRUITING